Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: prospective study
Not Applicable
- Conditions
- Atrial fibrillation
- Registration Number
- JPRN-UMIN000020636
- Lead Sponsor
- ational Cerebral and Cardiovascular Center Department of Cardiovascular Medicine Division of Arrhythmia and Electrophysiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients who could not receive anticoagulation (2) patients with severely impaired renal function (3) patients with absolute indication for warfarin (4) patients who are considered as ineligible for this study by attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method death, cerebral infarction, bleeding complication
- Secondary Outcome Measures
Name Time Method